Status:
UNKNOWN
Exercise and Genes in Obese (EGO)
Lead Sponsor:
Jarle Berge
Collaborating Sponsors:
University of South-Eastern Norway
Vestfold University College
Conditions:
Obesity
Eligibility:
All Genders
Phase:
NA
Brief Summary
Regular exercise has several positive health effects including increased physical fitness and muscle mass. It is well known that increased muscle mass is associated with increased resting energy expen...
Eligibility Criteria
Inclusion
- Treatment seeking weight stable morbidly obese patients (BMI ≥ 40 kg/m2 or BMI 35 to 39.9 kg/m2 with ≥ 1 co morbidity) attending the outpatient Obesity Center, Vestfold Hospital Trust, will be informed about this RCT .
Exclusion
- Uncompensated heart failure
- Recent myocardial infarction or stroke (\<½ years)
- Severe arrhythmia or heart failure
- Unstable angina pectoris
- Renal failure
- Pregnancy
- Severe eating disorders
- Active substance abuse
- Being on a diet
- Taking medication known to affect appetite or metabolism (including thyroxin).
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02311738
Start Date
January 1 2015
End Date
August 1 2023
Last Update
September 23 2021
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University School of Medicine
Durham, North Carolina, United States, 27708
2
Vestfold University College
Horten, Raveien, Norway, 3184
3
Telemark University College
Bø, Norway, 3800
4
University in Agder
Kristiansand, Norway, 4630